JP Morgan Chase’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

JP Morgan Chase’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-349,944	Closed	-$5.9M	–	7886
2023 Q2	$5.9M	Buy	+349,944	New	+$4.6M	﹤0.01%	2729

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return

JP Morgan Chase's VECT Position: Q3 2023 in Review

JP Morgan Chase sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 349,944 shares — an estimated $5.9M sold.

JP Morgan Chase first reported a position in VECT in Q2 2023 and held it in 1 quarter. The position peaked at $5.9M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

JP Morgan Chase reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
JP Morgan Chase sold 349,944 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $5.9M.
JP Morgan Chase first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2023 and held it in 1 quarter.
JP Morgan Chase's VectivBio Holding AG Ordinary Shares position peaked at $5.9M in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.